{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:44:58Z","timestamp":1794296698745,"version":"4.9.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.semnuclmed.2025.11.015","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:38:07Z","timestamp":1765197487000},"page":"364-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature"],"prefix":"10.1053","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-0967","authenticated-orcid":false,"given":"Morten","family":"Bentestuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dahlsgaard-Wallenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-3280","authenticated-orcid":false,"given":"Marie M.K.","family":"Stolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-288X","authenticated-orcid":false,"given":"Helle D.","family":"Zacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1053\/j.semnuclmed.2025.11.015_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143526","article-title":"Cancer-associated fibroblasts: implications for cancer therapy","volume":"13","author":"Maia","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.11.015_bib0002","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.21037\/jgo-24-374","article-title":"Systematic review and meta-analysis of the prognostic role of fibroblast-activation protein in gastrointestinal cancers","volume":"15","author":"Sunami","year":"2024","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.11.015_bib0003","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"18","key":"10.1053\/j.semnuclmed.2025.11.015_bib0004","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.11.015_bib0005","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0006","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2967\/jnumed.122.264689","article-title":"Fibroblast-activation protein PET and histopathology in a single-center database of 324 patients and 21 tumor entities","volume":"64","author":"Hirmas","year":"2023","journal-title":"J Nucl Med"},{"issue":"32","key":"10.1053\/j.semnuclmed.2025.11.015_bib0007","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics","volume":"37","author":"Pur\u00e9","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.acra.2025.07.034","article-title":"Beyond cancer: the role of radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in non-oncological molecular imaging","author":"Jafari","year":"2025","journal-title":"Acad Radiol"},{"issue":"7760","key":"10.1053\/j.semnuclmed.2025.11.015_bib0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0011","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","article-title":"Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases","volume":"207","author":"Yang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.11.015_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ph14101023","article-title":"New frontiers in cancer imaging and therapy based on radiolabeled fibroblast activation protein inhibitors: a rational review and current progress","volume":"14","author":"Imlimthan","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0013","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/life13091821","article-title":"Head-to-head comparison of FDG and radiolabeled FAPI PET: a systematic review of the literature","volume":"13","author":"Guglielmo","year":"2023","journal-title":"Life"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0015","article-title":"Head-to-head comparison of [(68)Ga]Ga-FAPI-04 PET and [(18)F]FDG PET in the evaluation of primary gastrointestinal tumors and metastases: a systematic review and meta-analysis","author":"Zhao","year":"2025","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0016","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","article-title":"FAPI-avid nonmalignant PET\/CT findings: an expedited systematic review","volume":"53","author":"Bentestuen","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0017","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.11.015_bib0018","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1007\/s00330-023-09952-y","article-title":"Potential utility of [(68)Ga]DOTA-FAPI-04 as a broad-spectrum benign disease imaging agent-comparison with [(18)F]FDG and [(99m)Tc]MDP","volume":"33","author":"Li","year":"2023","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.11.015_bib0019","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/RLU.0000000000005353","article-title":"Increased 68 Ga-FAPI-04 uptake in meningioma","volume":"49","author":"\u00d6nner","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"18","key":"10.1053\/j.semnuclmed.2025.11.015_bib0020","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.7150\/thno.103399","article-title":"(68)Ga-FAPI-46 PET\/CT in the evaluation of gliomas: comparison with (18)F-FDG PET\/CT and contrast-enhanced MRI","volume":"14","author":"Ruan","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/RLU.0000000000005458","article-title":"68 Ga-FAPI PET in visualizing acute ischemic stroke at risk of hemorrhagic transformation","volume":"50","author":"Kim","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.11.015_bib0022","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/RLU.0000000000003790","article-title":"Cerebral venous sinus thrombosis caused by neuro-beh\u00e7et disease accidentally detected by 68Ga-FAPI PET\/CT","volume":"46","author":"Lin","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0023","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-021-02962-0","article-title":"A case of papillary thyroid carcinoma with Graves ophthalmopathy evaluated by Ga-68-FAPI PET\/CT","volume":"76","author":"Rao","year":"2022","journal-title":"Endocrine"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.11.015_bib0024","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.121.262808","article-title":"Pitfalls and common findings in 68Ga-FAPI-PET \u2013 a pictorial analysis","volume":"63","author":"Kessler","year":"2022","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.11.015_bib0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s12149-021-01673-w","article-title":"Characterization of the benign lesions with increased Ga-68-FAPI-04 uptake in PET\/CT","volume":"35","author":"Zheng","year":"2021","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.11.015_bib0026","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00259-021-05203-8","article-title":"Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET\/CT","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2025.11.015_bib0027","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MNM.0000000000001563","article-title":"Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET\/CT imaging","volume":"43","author":"Kou","year":"2022","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-024-01129-y","article-title":"[(68)Ga]Ga-FAPI versus 2-[(18)F]FDG PET\/CT in patients with autoimmune thyroiditis: a case control study","volume":"14","author":"Pabst","year":"2024","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0029","article-title":"Clinical significance of diffusely increased uptake of Ga-68-FAPI in thyroid gland","author":"Liu","year":"2021","journal-title":"Front Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11307-022-01759-5","article-title":"Distinguishing benign and malignant findings on [68 Ga]-FAPI PET\/CT based on quantitative SUV measurements","volume":"25","author":"Dabir","year":"2023","journal-title":"Mol Imaging Biol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0031","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac Fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.11.015_bib0032","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","article-title":"Myocardial fibroblast activation after acute myocardial infarction: a positron emission tomography and magnetic resonance study","volume":"85","author":"Barton","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0033","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.124.268376","article-title":"Targeting fibroblast activation protein for molecular imaging of fibrotic remodeling in pulmonary arterial hypertension","volume":"66","author":"Hou","year":"2025","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0034","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221052","article-title":"Myocardial activity at 18F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy","volume":"306","author":"Wang","year":"2023","journal-title":"Radiology"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.11.015_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcmg.2024.10.001","article-title":"Molecular stratification of light-chain cardiac amyloidosis with18F-florbetapir and 68Ga-FAPI-04 for enhanced prognostic precision","volume":"18","author":"Wang","year":"2025","journal-title":"JACC-Cardiovasc Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2025.11.015_bib0036","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jcmg.2024.04.003","article-title":"FAPI PET imaging supports clinical decision making in academic cardiology practice: a pictorial imaging vignette","volume":"17","author":"Settelmeier","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.11.015_bib0037","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s12350-023-03352-x","article-title":"Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study","volume":"30","author":"Li","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0038","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-023-03220-8","article-title":"Visualization of fibroblast activation using (68)Ga-FAPI PET\/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation","author":"Kupusovic","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.11.015_bib0039","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s00330-023-10208-y","article-title":"Value of [(18)F]AlF-NOTA-FAPI-04 PET\/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [(18)F]FDG PET\/CT","volume":"34","author":"Qiao","year":"2024","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0040","first-page":"654","article-title":"Value of semi-quantitative parameters of (68)Ga-FAPI-04 PET\/CT in primary malignant and benign diseases: a comparison with (18)F-FDG","volume":"39","author":"Li","year":"2024","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study","volume":"63","author":"R\u00f6hrich","year":"2022","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.11.015_bib0042","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/RLU.0000000000004437","article-title":"Enhancing clinical diagnosis for patients with persistent pulmonary abnormalities after COVID-19 infection: the potential benefit of 68 Ga-FAPI PET\/CT","volume":"47","author":"Sviridenko","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.11.015_bib0043","doi-asserted-by":"crossref","first-page":"E534","DOI":"10.1097\/RLU.0000000000003598","article-title":"Solitary fibrous tumors of the pleura shown on F-18-FDG and Ga-68-DOTA-FAPI-04 PET\/CT","volume":"46","author":"Zhang","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13550-024-01145-y","article-title":"Role of [(18)F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [(18)F]FDG PET\/CT","volume":"14","author":"Liang","year":"2024","journal-title":"EJNMMI Res"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.11.015_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/RLU.0000000000005504","article-title":"Negative 18 F-FDG and positive 68 Ga-FAPI-04 findings in a patient with acute exacerbation of chronic cholecystitis","volume":"50","author":"Qi","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43049-2","article-title":"Comparison of early and late (68)Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas","volume":"13","author":"Hoppner","year":"2023","journal-title":"Sci Rep"},{"issue":"12","key":"10.1053\/j.semnuclmed.2025.11.015_bib0047","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1007\/s00259-024-06773-z","article-title":"Non-invasive visualization of liver fibrosis with [(68)Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation","volume":"51","author":"Song","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0048","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/RLU.0000000000004965","article-title":"Elevated 18 F-AIF-FAPI-04 uptake in hepatic hemangioma","volume":"49","author":"Sun","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0049","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1097\/RLU.0000000000004122","article-title":"Primary solitary tuberculosis in the hepatic round ligament detected by 68Ga-FAPI PET\/CT","volume":"47","author":"Deng","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0050","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1007\/s00259-023-06236-x","article-title":"Identification of isolated hepatic sarcoidosis with [(18)F]FDG and [(68) Ga]Ga-FAPI PET\/CT","volume":"50","author":"Pang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0051","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.acra.2024.07.032","article-title":"The role of FAPI PET imaging in pancreatic cancer: a meta-analysis compared with 18F-FDG PET","volume":"32","author":"Hu","year":"2025","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0052","first-page":"93","article-title":"Diagnostic potential of static and dynamic 68Ga-FAPI PET\/CT for the differentiation of mass forming pancreatitis and pancreatic ductal adenocarcinomas","volume":"63","author":"R\u00f6hrich","year":"2024","journal-title":"Nukl - Nucl"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0053","article-title":"Non-specific uptake of 18F-FAPI-04 in the pancreas and its related factors: a post-hoc analysis of an ongoing prospective clinical trial","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1053\/j.semnuclmed.2025.11.015_bib0054","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s00259-021-05194-6","article-title":"Non-malignant findings of focal (68)Ga-FAPI-04 uptake in pancreas","volume":"48","author":"Zhang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.11.015_bib0055","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","article-title":"(68) Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease","volume":"49","author":"Conen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0056","doi-asserted-by":"crossref","DOI":"10.1007\/s11307-023-01820-x","article-title":"A comparative study of (18)F-FAPI-42 and (18)F-FDG PET\/CT for evaluating acute kidney injury in cancer patients","author":"Chi","year":"2023","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0057","doi-asserted-by":"crossref","first-page":"sfae064","DOI":"10.1093\/ckj\/sfae064","article-title":"(18)F] AlF-NOTA-FAPI-04 PET\/CT for non-invasive assessment of tubular injury in kidney diseases","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0058","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-023-06107-5","article-title":"68Ga]Ga-FAPI-04 PET\/CT on assessing Crohn\u2019s disease intestinal lesions","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0059","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000005815","article-title":"Head-to-head comparison of 68Ga-FAPI-04 and 18F-FDG PET\/CT for the assessment of Crohn's disease: a prospective pilot study","author":"Pan","year":"2025","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0060","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of intestinal fibrosis with 68Ga-FAPI PET\/MR enterography in Crohn disease","author":"Scharitzer","year":"2023","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15020218","article-title":"First clinical experience of (68)Ga-FAPI PET\/CT in tertiary cancer center: identifying pearls and pitfalls","volume":"15","author":"Al-Ibraheem","year":"2025","journal-title":"Diagnostics"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0062","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/RLU.0000000000005537","article-title":"Predicting malignancy in adnexal tumors with FAPI PET\/CT and FDG PET\/CT: a case report on a borderline ovarian tumor","volume":"50","author":"Umachanger","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0063","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2967\/jnumed.123.266732","article-title":"[(68)Ga]Ga-FAPI-46 PET in a borderline ovarian tumor","volume":"65","author":"Unterrainer","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.989595","article-title":"Non-tumoral uptake of (68)Ga-FAPI-04 PET: a retrospective study","volume":"12","author":"Qi","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0065","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar1877","article-title":"Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis","volume":"8","author":"Milner","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0066","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222052","article-title":"(68)Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study","author":"Luo","year":"2023","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0067","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-025-11610-4","article-title":"Fibroblast activation imaging in rheumatoid arthritis: evaluating disease activity and treatment response using [(18)F]FAPI PET\/CT","author":"Mu","year":"2025","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2025.11.015_bib0068","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004294","article-title":"Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis","volume":"10","author":"Corte","year":"2024","journal-title":"RMD Open"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.11.015_bib0069","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","article-title":"Value of [Ga-68]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis","volume":"48","author":"Zhou","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.11.015_bib0070","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/rheumatology\/keae505","article-title":"Fibroblast activation protein inhibitor positron emission tomography imaging in muscles of patients with idiopathic inflammatory myopathy","volume":"64","author":"Zhang","year":"2025","journal-title":"Rheumatology"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0071","article-title":"Incidental intense Fibroblast Activation Protein Inhibitor (FAPI) uptake in bilateral gluteal myositis ossificans: a case report","volume":"16","author":"Al-Rashdan","year":"2024","journal-title":"Cureus"},{"issue":"10","key":"10.1053\/j.semnuclmed.2025.11.015_bib0072","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.11.015_bib0073","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2967\/jnumed.121.262863","article-title":"Feasibility of in vivo imaging of fibroblast activation protein in human arterial walls","volume":"63","author":"Wu","year":"2022","journal-title":"J Nucl Med"},{"issue":"14","key":"10.1053\/j.semnuclmed.2025.11.015_bib0074","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202411152","article-title":"Fibroblast activation protein acts as a biomarker for monitoring ECM remodeling during aortic aneurysm via (68)Ga-FAPI-04 PET imaging","volume":"12","author":"Hu","year":"2025","journal-title":"Adv Sci"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017967","article-title":"Exploration of (68)Ga-FAPI-04 PET\/MR in chronic type B aortic dissection","author":"Hu","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.11.015_bib0076","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00259-024-06986-2","article-title":"Comparison of [(18)F]FAPI-42 and [(18)F]FDG PET\/CT in the evaluation of systemic vasculitis","volume":"52","author":"Zhong","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.11.015_bib0077","doi-asserted-by":"crossref","DOI":"10.3390\/ph17111468","article-title":"[68Ga]Ga-FAPI-46 PET\/CT for staging suspected\/confirmed lung cancer: results on the surgical cohort within a monocentric prospective trial","volume":"17","author":"Zanoni","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1053\/j.semnuclmed.2025.11.015_bib0078","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/RLU.0000000000004913","article-title":"68 Ga-FAPI-04 PET\/CT in assessment of fibroblast activation in keloids: a prospective pilot study","volume":"49","author":"Wang","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2025.11.015_bib0079","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/RLU.0000000000005371","article-title":"Postoperative spindle cell nodule mimicking metastatic lesion with persistently increasing 68 Ga-FAPI-04 uptake after receiving personalized antigen peptide tumor vaccine","volume":"49","author":"Wang","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2025.11.015_bib0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00259-021-05522-w","article-title":"The potential utility of [(68) Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [F-18]FDG","volume":"49","author":"Lan","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0081","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11307-024-01928-8","article-title":"Volume-based quantitative measurement of [(18)F]AlF-NOTA-FAPI-04 PET\/CT uptake reflects the disease activity of IgG4-related disease","volume":"26","author":"Wan","year":"2024","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2025.11.015_bib0082","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2967\/jnumed.124.268943","article-title":"Differences in fibroinflammatory activity shown on (68)Ga-FAPI-04 and (18)F-FDG PET\/CT in the two subtypes of IgG4-related disease","volume":"66","author":"Liu","year":"2025","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0083","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/RLU.0000000000004752","article-title":"Prospective comparison of the imaging value of <SUP>99m<\/SUP>Tc-MDP bone scan and <SUP>68<\/SUP>Ga-FAPI-04 PET\/CT in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome","volume":"48","author":"Xu","year":"2023","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0084","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/RLU.0000000000004724","article-title":"Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET\/CT in patients with SAPHO syndrome","volume":"48","author":"Wang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.015_bib0085","article-title":"Diagnostic performance of [(68)Ga]Ga-FAPI-04 PET vs. [(18)F]FDG PET in detecting lymph node metastasis in digestive system cancers: a head-to-head comparative meta-analysis","volume":"12","author":"Li","year":"2025","journal-title":"Front Med"},{"issue":"1142","key":"10.1053\/j.semnuclmed.2025.11.015_bib0086","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/CT imaging","volume":"96","author":"Hotta","year":"2023","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2025.11.015_bib0087","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.semnuclmed.2024.02.006","article-title":"FAPI-PET in cardiovascular disease","volume":"54","author":"Higuchi","year":"2024","journal-title":"Semin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2025.11.015_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103856","article-title":"Radio-labelled fibroblast activation protein inhibitors in interstitial lung diseases - a systematic review","volume":"24","author":"Bundgaard-Nielsen","year":"2025","journal-title":"Autoimmun Rev"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825001680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825001680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:51:07Z","timestamp":1773845467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299825001680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0001299825001680"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.11.015","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}